A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".

Saved in:
Bibliographic Details
Title: A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".
Authors: Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. m.augustin@uke.de., Armstrong AW; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Issa NT; Forefront Dermatology, Vienna, VA, USA.; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.; George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Petersen AS; LEO Pharma A/S, Ballerup, Denmark., von Eyben R; LEO Pharma A/S, Ballerup, Denmark., Festini T; LEO Pharma A/S, Ballerup, Denmark., Torres T; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.; Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Letter
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb)
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42360589
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Augustin+M%22">Augustin M</searchLink>; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. m.augustin@uke.de.<br /><searchLink fieldCode="AU" term="%22Armstrong+AW%22">Armstrong AW</searchLink>; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Issa+NT%22">Issa NT</searchLink>; Forefront Dermatology, Vienna, VA, USA.; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.; George Washington University School of Medicine and Health Sciences, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Petersen+AS%22">Petersen AS</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22von+Eyben+R%22">von Eyben R</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Festini+T%22">Festini T</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Torres+T%22">Torres T</searchLink>; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.; Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jun 26. <i>Date of Electronic Publication: </i>2026 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42360589
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-026-01798-8
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Augustin M
      – PersonEntity:
          Name:
            NameFull: Armstrong AW
      – PersonEntity:
          Name:
            NameFull: Issa NT
      – PersonEntity:
          Name:
            NameFull: Petersen AS
      – PersonEntity:
          Name:
            NameFull: von Eyben R
      – PersonEntity:
          Name:
            NameFull: Festini T
      – PersonEntity:
          Name:
            NameFull: Torres T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2026 Jun 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1